Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Momoko Okuda

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|January 31, 2015
Single-molecule analyses of the dynamics of heat shock protein 104 (Hsp104) and protein aggregatesMomoko Okuda, Tatsuya Niwa, Hideki Taguchi
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2020
Dynamics of oligomer and amyloid fibril formation by yeast prion Sup35 observed by high-speed atomic force microscopyHiroki Konno, Takahiro Watanabe-Nakayama, Takayuki Uchihashi, et al.
The Journal of Toxicological Sciences|July 2, 2023
Preclinical in vitro evaluation of immune suppression induced by GYM329, Fc-engineered sweeping antibodyYoshika Iwata, Hitoshi Katada, Momoko Okuda, et al.
The FEBS Journal|November 20, 2014
Peptide sequences converting polyglutamine into a prion in yeastWataru Odani, Kazuhiro Urata, Momoko Okuda, et al.
Neuropsychiatric Disease and Treatment|January 27, 2017
Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trialTaro Kishi, Yuki Matsuda, Shinji Matsunaga, et al.
Comprehensive Psychiatry|March 1, 2015
A cross-sectional survey to investigate the prevalence of pain in Japanese patients with major depressive disorder and schizophreniaTaro Kishi, Yuki Matsuda, Tomohiko Mukai, et al.
Scientific Reports|January 26, 2021
Novel myostatin-specific antibody enhances muscle strength in muscle disease modelsHiroyasu Muramatsu, Taichi Kuramochi, Hitoshi Katada, et al.
Mabs|March 16, 2022
Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variantsTaichi Kuramochi, Siok Wan Gan, Adrian W S Ho, et al.
Ebiomedicine|November 8, 2025
Long lasting complement neutralisation by RAY121, an engineered anti-C1s antibody with C1q displacement functionAdrian W S Ho, Taku Fukuzawa, Hikaru Koga, et al.
Journal of Thrombosis and Haemostasis : JTH|November 8, 2023
A bispecific antibody NXT007 exerts a hemostatic activity in hemophilia A monkeys enough to keep a nonhemophilic stateYuri Teranishi-Ikawa, Tetsuhiro Soeda, Hikaru Koga, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|January 31, 2015
Single-molecule analyses of the dynamics of heat shock protein 104 (Hsp104) and protein aggregatesMomoko Okuda, Tatsuya Niwa, Hideki Taguchi
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2020
Dynamics of oligomer and amyloid fibril formation by yeast prion Sup35 observed by high-speed atomic force microscopyHiroki Konno, Takahiro Watanabe-Nakayama, Takayuki Uchihashi, et al.
The Journal of Toxicological Sciences|July 2, 2023
Preclinical in vitro evaluation of immune suppression induced by GYM329, Fc-engineered sweeping antibodyYoshika Iwata, Hitoshi Katada, Momoko Okuda, et al.
The FEBS Journal|November 20, 2014
Peptide sequences converting polyglutamine into a prion in yeastWataru Odani, Kazuhiro Urata, Momoko Okuda, et al.
Neuropsychiatric Disease and Treatment|January 27, 2017
Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trialTaro Kishi, Yuki Matsuda, Shinji Matsunaga, et al.
Comprehensive Psychiatry|March 1, 2015
A cross-sectional survey to investigate the prevalence of pain in Japanese patients with major depressive disorder and schizophreniaTaro Kishi, Yuki Matsuda, Tomohiko Mukai, et al.
Scientific Reports|January 26, 2021
Novel myostatin-specific antibody enhances muscle strength in muscle disease modelsHiroyasu Muramatsu, Taichi Kuramochi, Hitoshi Katada, et al.
Mabs|March 16, 2022
Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variantsTaichi Kuramochi, Siok Wan Gan, Adrian W S Ho, et al.
Ebiomedicine|November 8, 2025
Long lasting complement neutralisation by RAY121, an engineered anti-C1s antibody with C1q displacement functionAdrian W S Ho, Taku Fukuzawa, Hikaru Koga, et al.
Journal of Thrombosis and Haemostasis : JTH|November 8, 2023
A bispecific antibody NXT007 exerts a hemostatic activity in hemophilia A monkeys enough to keep a nonhemophilic stateYuri Teranishi-Ikawa, Tetsuhiro Soeda, Hikaru Koga, et al.
Pageof 1